# National Lung Cancer Registry in Men and Women Based on Diagnosis in Algeria

> **NCT02725892** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 897 (actual)

## Conditions studied

- Oncology & Epidemiology & Lung Cancer

## Interventions

- **OTHER:** NIS observational stud

## Key facts

- **NCT ID:** NCT02725892
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-19
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 897 (ACTUAL)
- **Last updated:** 2022-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02725892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02725892, "National Lung Cancer Registry in Men and Women Based on Diagnosis in Algeria". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02725892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*